Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction
NCT ID: NCT02382445
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138 participants
INTERVENTIONAL
2014-01-31
2017-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators' prospective randomized trial is underway to verify the impact of anesthetics and narcotic depth upon grade of dementia and incidence of early postoperative cognitive dysfunction on postoperative day 1 as well as the incidence of delirium within a 90 day period.
The investigators' hypothesis is that the incidence of POCD and delirium and the degree of early cognitive dysfunction is less when anesthetic and vasoactive drug load is less in the BIS- guided anesthesia group with the superficial but sufficient anesthesia level.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoperative EEG Monitoring and Postoperative Delirium in Elderly Patients With Sevoflurane Anesthesia
NCT04292561
Intraoperative Sedation and Postoperative Delirium
NCT02573558
The Neuro-epigenetics Biomarkers of Postoperative Delirium in Elderly Patients Undergoing Hip/Knee Replacement
NCT04923243
Anesthesia Depth Increases Delirium Incidence
NCT05656703
Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's Disease
NCT01870453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anesthesia depth monitor
Anesthesia depth is aimed to be between BIS 50-60
Anesthesia depth monitor
propofol and sevoflurane
Control group
Anesthesia depth is monitored but blinded to the anesthesiologist
Sham control
Standard care as usual. Bis m Standard care as usual. Bispectral index monitor is not visible for anesthesia provider.
propofol and sevoflurane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anesthesia depth monitor
Sham control
Standard care as usual. Bis m Standard care as usual. Bispectral index monitor is not visible for anesthesia provider.
propofol and sevoflurane
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* major surgery ( spine, orthopedic, urologic, gynecology, abdominal)
Exclusion Criteria
* major blood loss surgery
* allergy to soja oil, nuts, other ingredients of propofol
* patient wants to have spinal or regional anesthesia only
18 Years
110 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Frietsch
Prof. Dr. med. Thomas Frietsch
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Frietsch, Prof, MD
Role: STUDY_DIRECTOR
Universitätsmedizin Mannheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diakonissen Hospital
Mannheim, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIS-Diako-Ma-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.